Jose I. Mendez-Sanchez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Medium-Term Outcomes of Cryoablation for Nonoperative Management of Clinical T1-2N0 ER-Positive/HER2-Negative Breast Cancer in Elderly or Comorbid Women.

Medium-Term Outcomes of Cryoablation for Nonoperative Management of Clinical T1-2N0 ER-Positive/HER2-Negative Breast Cancer in Elderly or Comorbid Women.

Journal: Journal of vascular and interventional radiology : JVIR
Published: January 21, 2026

Research on differences in sexual orientation and identity.

Research on differences in sexual orientation and identity.

Journal: AIDS reviews
Published: December 22, 2025

Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer.

Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer.

Journal: Current oncology (Toronto, Ont.)
Published: December 01, 2025

Axillary surgery in the cyclin-dependent kinase 4/6 inhibitors era: no time to move backward.

Axillary surgery in the cyclin-dependent kinase 4/6 inhibitors era: no time to move backward.

Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: November 24, 2025

Natural procreative technology (NaProTechnology) for infertility: take-home baby rate and clinical outcomes in a 5-year single-center cohort of 1,310 couples.

Natural procreative technology (NaProTechnology) for infertility: take-home baby rate and clinical outcomes in a 5-year single-center cohort of 1,310 couples.

Journal: Frontiers in reproductive health
Published: September 01, 2025

Current Indications for Seed-Marked Axillary Lymph Node Dissection in Breast Cancer.

Current Indications for Seed-Marked Axillary Lymph Node Dissection in Breast Cancer.

Journal: Cancers
Published: March 25, 2025

Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.

Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.

Journal: Breast cancer research and treatment
Published: January 10, 2025

A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict® Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma.

A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict® Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma.

Journal: Cancers
Published: December 04, 2024

Correction: Survival in pregnancy-associated breast cancer patients compared to non-pregnant controls.

Correction: Survival in pregnancy-associated breast cancer patients compared to non-pregnant controls.

Journal: Reproductive biology and endocrinology : RB&E
Published: June 15, 2024

Pre-surgical cryoablation in ≤ 2 cm ER + /HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma.

Pre-surgical cryoablation in ≤ 2 cm ER + /HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma.

Journal: Breast cancer research and treatment
Published: February 07, 2024

Survival in pregnancy-associated breast cancer patients compared to non-pregnant controls.

Survival in pregnancy-associated breast cancer patients compared to non-pregnant controls.

Journal: Reproductive biology and endocrinology : RB&E
Published: January 26, 2024

Breast-Conserving Surgery Guided with Magnetic Seeds vs. Wires: A Single-Institution Experience.

Breast-Conserving Surgery Guided with Magnetic Seeds vs. Wires: A Single-Institution Experience.

Journal: Cancers
Published: December 16, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026